Pulmonary Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years old or older and have been diagnosed with a scarring lung disease, a condition that blocks the small airways in the lungs, or high blood pressure in the lung's blood vessels (pulmonary arterial hypertension), and you are being considered for or have already had a lung transplant.
- You are willing and able to give your agreement (consent) to take part in the study, whether you are joining now or have been a patient at the center before.
Who may not be able to join:
- You have been diagnosed with, or doctors suspect you may have, a cancerous or tumour-related condition affecting the lungs.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +39 0382503460
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Complete synthesis and characterization of XHALIP for in vitro studies.; Complete synthesis and characterization of XHALIP for in vitro studies.; Complete synthesis and characterization of XHALIP for in vitro studies.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.